跳至主要内容
临床试验/CTRI/2025/02/081365
CTRI/2025/02/081365尚未招募2 期

A comprative evaluation of itrifal fauladi with majoon khabsul hadeed in the management of su-al-qinya (iron deficiency anemia): An open label randomized clinical trial.

Govt Tibbi College And Hospital Patna1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Haemoglobin

研究概览

简要总结

patient fulfilling the inclusion criteria will be inrolled in the study after obtained the informed consent. A detailed history subjective and objective parameter will  be evaluated at each visit. All subjective and objective parameter will be assessed. Treatment protocol explained well to the patient will be instructed not take any other medication during trial. treatment will be given for 60 days in semisolid compound form. and symptoms will be assessed on each visit followed by post trial investigation. All finding will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • patient having hemoglobin between 7gm/dl to 12gm/dl.
  • MCV less than 80fl
  • MCH less than 26pg
  • MCHC less than 31gm/dl
  • Serum ferratin less than 10mcg
  • Patient suffering from Microcytic hypochromic anaemia on Blood Peripheral smear/.

排除标准

  • Patients not willing to sign the consent form.
  • Patient below the age of 18 years and above the age of 65 years.
  • Pregnant and lactating women.
  • Patient already taking treatment for anemia.
  • Patients suffering from malignancy, Hypertension, Diabetes mellitus.
  • Patients with any bleeding history e.g., Abnormal uterine bleeding, piles/rectal bleeding, haemoptysis and hematemesis etc.
  • Patients with chronic renal failure.
  • Patients suffering from thalassemia /sickle cell disease and any other haemolytic disorders.
  • Patients taking blood thinners or any other drug which causes haemolysis.

结局指标

主要结局

1. Haemoglobin

时间窗: at baseline, 30 days, and 60 days

2. Peripheral blood smear

时间窗: at baseline, 30 days, and 60 days

3. Serum ferritin

时间窗: at baseline, 30 days, and 60 days

次要结局

  • 1. Pallor.(2. Fatigue.)

研究者

发起方
Govt Tibbi College And Hospital Patna
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

KM SUCHITA

Govt. Tibbi College And Hospital Patna

研究点 (1)

Loading locations...

相似试验